CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses
复制标题

DOI:
10.1073/pnas.1834479100
复制
发表时间:
2003-09-16
影响因子:
11.1
通讯作者:
Shiku, H
Shiku, H
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Nishikawa, H;Kato, T;Shiku, H

文献摘要

被引文献

相似文献

通过重组表达克隆(SEREX)(一种血清学表达克隆方法)对抗原进行血清学鉴定,已经通过肿瘤携带者血清中的IgG抗体定义了多种肿瘤衍生抗原。这些抗原中的大多数没有显示出结构异常,似乎是野生型自身抗原。用编码这些自身抗原和肿瘤特异性细胞毒性T淋巴细胞表位的DNA共免疫增强了CD 8(+)T细胞应答,并以CD 4(+)T细胞依赖性方式增加了对肿瘤攻击的抵抗力。相比之下,单独用这些SEREX定义的自身抗原免疫导致对肿瘤攻击的易感性增加。免疫的这种抑制作用由CD 4(+)CD 25(+)T细胞介导。在用SEREX定义的自身抗原之一DNA J样2免疫的小鼠中,在肺室中α-GalCer/CD 1d四聚体(+)CD 3(+)T细胞[代表自然杀伤T(NKT)细胞]的数量减少,而未观察到其他T细胞亚群数量的明显变化。用缺乏大多数NKT细胞的Jalpha 281(-/-)小鼠进行的实验表明,NKT细胞主要负责转移抑制,并且它们的活性被用DNA J样2免疫抑制。我们认为SEREX鉴定了一组自身抗原,这些抗原通过CD 4(+)CD 25(+)调节性T细胞维持和调节免疫稳态。
A variety of tumor-derived antigens have been defined by IgG antibodies in tumor bearers' sera with serological identification of antigens by recombinant expression cloning (SEREX), a serological expression cloning method. The majority of these antigens show no structural abnormality and seem to be wild-type autoantigens. Coimmunization with DNA encoding these autoantigens and tumor-specific cytotoxic T lymphocytes epitopes heightened CD8(+) T cell responses and increased resistance to tumor challenge in a CD4(+) T cell-dependent manner. In contrast, immunization with these SEREX-defined autoantigens alone leads to heightened susceptibility to tumor challenge. This suppressive effect of immunization is mediated by CD4(+) CD25(+) T cells. In mice immunized with one of the SEREX-defined autoantigens, Dna J-like 2, the number of alpha-GalCer/CD1d tetramer(+) CD3(+) T cells [representing natural killer T (NKT) cells] was reduced in the pulmonary compartment, whereas no evident change in the number of other T cell subsets was observed. Experiments with Jalpha281(-/-) mice lacking most NKT cells indicate that NKT cells are primarily responsible for metastasis suppression and that their activity is inhibited by immunization with Dna J-like 2. We propose that SEREX identifies a pool of autoantigens that maintains and regulates immunological homeostasis via CD4(+) CD25(+) regulatory T cells.